Adult diagnoses (age 15 through 124)

Adult diagnoses (age 15 through 124). — See additional coding rules

Z12.4 Encounter for screening for malignant neoplasm of cervix
Z12.6 Encounter for screening for malignant neoplasm of bladder
Z12.71 Encounter for screening for malignant neoplasm of testis
Z12.72 Encounter for screening for malignant neoplasm of vagina
Z12.73 Encounter for screening for malignant neoplasm of ovary
Z12.79 Encounter for screening for malignant neoplasm of other genitourinary organs
Z12.81 Encounter for screening for malignant neoplasm of oral cavity
Z12.82 Encounter for screening for malignant neoplasm of nervous system
Z12.83 Encounter for screening for malignant neoplasm of skin
Z12.89 Encounter for screening for malignant neoplasm of other sites
Z12.9 Encounter for screening for malignant neoplasm, site unspecified
Z13.0 Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Z13.1 Encounter for screening for diabetes mellitus
Z13.21 Encounter for screening for nutritional disorder
Z13.220 Encounter for screening for lipoid disorders
Z13.228 Encounter for screening for other metabolic disorders
Z13.29 Encounter for screening for other suspected endocrine disorder
Z13.30 Encounter for screening examination for mental health and behavioral disorders, unspecified
Z13.31 Encounter for screening for depression
Z13.32 Encounter for screening for maternal depression
Z13.39 Encounter for screening examination for other mental health and behavioral disorders
Z13.40 Encounter for screening for unspecified developmental delays
Z13.41 Encounter for autism screening
Z13.42 Encounter for screening for global developmental delays (milestones)
Z13.49 Encounter for screening for other developmental delays
Z13.5 Encounter for screening for eye and ear disorders
Z13.6 Encounter for screening for cardiovascular disorders
Z13.71 Encounter for nonprocreative screening for genetic disease carrier status
Z13.79 Encounter for other screening for genetic and chromosomal anomalies
Z13.810 Encounter for screening for upper gastrointestinal disorder
Z13.811 Encounter for screening for lower gastrointestinal disorder
Z13.818 Encounter for screening for other digestive system disorders
Z13.820 Encounter for screening for osteoporosis
Z13.828 Encounter for screening for other musculoskeletal disorder
Z13.83 Encounter for screening for respiratory disorder NEC
Z13.84 Encounter for screening for dental disorders
Z13.850 Encounter for screening for traumatic brain injury
Z13.858 Encounter for screening for other nervous system disorders
Z13.88 Encounter for screening for disorder due to exposure to contaminants
Z13.89 Encounter for screening for other disorder
Z13.9 Encounter for screening, unspecified
Z14.01 Asymptomatic hemophilia A carrier
Z14.02 Symptomatic hemophilia A carrier
Z14.1 Cystic fibrosis carrier
Z14.8 Genetic carrier of other disease
Z15.01 Genetic susceptibility to malignant neoplasm of breast
Z15.02 Genetic susceptibility to malignant neoplasm of ovary
Z15.03 Genetic susceptibility to malignant neoplasm of prostate
Z15.04 Genetic susceptibility to malignant neoplasm of endometrium
Z15.09 Genetic susceptibility to other malignant neoplasm
Z15.81 Genetic susceptibility to multiple endocrine neoplasia [MEN]
Z15.89 Genetic susceptibility to other disease
Z16.10 Resistance to unspecified beta lactam antibiotics
Z16.11 Resistance to penicillins
Z16.12 Extended spectrum beta lactamase (ESBL) resistance
Z16.19 Resistance to other specified beta lactam antibiotics
Z16.20 Resistance to unspecified antibiotic
Z16.21 Resistance to vancomycin
Z16.22 Resistance to vancomycin related antibiotics
Z16.23 Resistance to quinolones and fluoroquinolones
Z16.24 Resistance to multiple antibiotics
Z16.29 Resistance to other single specified antibiotic
Z16.30 Resistance to unspecified antimicrobial drugs
Z16.31 Resistance to antiparasitic drug(s)
Z16.32 Resistance to antifungal drug(s)
Z16.33 Resistance to antiviral drug(s)
Z16.341 Resistance to single antimycobacterial drug
Z16.342 Resistance to multiple antimycobacterial drugs
Z16.35 Resistance to multiple antimicrobial drugs
Z16.39 Resistance to other specified antimicrobial drug
Z17.0 Estrogen receptor positive status [ER+]
Z17.1 Estrogen receptor negative status [ER-]
Z18.01 Retained depleted uranium fragments
Z18.09 Other retained radioactive fragments
Z18.10 Retained metal fragments, unspecified
Z18.11 Retained magnetic metal fragments
Z18.12 Retained nonmagnetic metal fragments
Z18.2 Retained plastic fragments
Z18.31 Retained animal quills or spines
Z18.32 Retained tooth
Z18.33 Retained wood fragments
Z18.39 Other retained organic fragments
Z18.81 Retained glass fragments
Z18.83 Retained stone or crystalline fragments
Z18.89 Other specified retained foreign body fragments
Z18.9 Retained foreign body fragments, unspecified material
Z19.1 Hormone sensitive malignancy status
Z19.2 Hormone resistant malignancy status
Z20.09 Contact with and (suspected) exposure to other intestinal infectious diseases
Z20.1 Contact with and (suspected) exposure to tuberculosis
Z20.2 Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission
Z20.3 Contact with and (suspected) exposure to rabies
Z20.4 Contact with and (suspected) exposure to rubella
Z20.7 Contact with and (suspected) exposure to pediculosis, acariasis and other infestations
Z20.810 Contact with and (suspected) exposure to anthrax
Z20.818 Contact with and (suspected) exposure to other bacterial communicable diseases
Z20.821 Contact with and (suspected) exposure to Zika virus
Z20.89 Contact with and (suspected) exposure to other communicable diseases
Z20.9 Contact with and (suspected) exposure to unspecified communicable disease
Z22.0 Carrier of typhoid